July 15, 2026 - 08:51

BOULDER, Colo., July 15, 2026 -- Laird Superfood, Inc. announced today that Anya Hamill will resign from her role as Chief Financial Officer, with her departure effective August 31, 2026. The company, known for its plant-based creamers and functional mushroom products, stated that Hamill's exit is not due to any disagreement with its financial practices or operations. The search for a new CFO has already begun, and the company expects to name a successor before Hamill's last day. During the transition period, Hamill will assist with the handover to ensure continuity. Laird Superfood has faced a challenging market environment over the past year, with fluctuating revenues and ongoing efforts to streamline costs. The resignation adds to a period of leadership changes as the company works to stabilize its balance sheet and expand distribution. Hamill had served as CFO since 2022, overseeing financial strategy during a time of restructuring and product line adjustments. The company did not provide further details on her future plans.
August 29, 2026 - 00:42
Why Rubrik Stock Is Plummeting TodayShares of Rubrik took a sharp hit today, with the stock falling more than 12 percent in morning trading. The drop comes after the data security company reported quarterly results that showed a...
August 28, 2026 - 04:10
Michael Burry Thanks Tech Columnist’s Praise For Making ‘A Killing’ On NVDA, MSFT Calls Into EarningsInvestor Michael Burry, best known for betting against the housing market before the 2008 crash, has acknowledged a tech columnist`s compliment about his recent options trades. The acknowledgment...
August 27, 2026 - 21:27
Texas is on RBC's map to grow its City National Bank unitRoyal Bank of Canada is setting its sights on Texas as a key market for expanding its City National Bank subsidiary. Senior executives at the Toronto-based lender said they see strong organic...
August 27, 2026 - 11:07
Junshi Biosciences Announces 2026 Interim Financial Results and Provides Corporate UpdatesShanghai, August 26, 2026 - Shanghai Junshi Biosciences, a biopharmaceutical company focused on creating new treatments, has shared its financial results for the first half of 2026. The company...